These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 19063929

  • 1. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
    Lee CH, Kuo WC, Beri S, Kapre S, Joshi JS, Bouveret N, LaForce FM, Frasch CE.
    Vaccine; 2009 Jan 29; 27(5):726-32. PubMed ID: 19063929
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C.
    Pediatr Infect Dis J; 2012 Jan 29; 31(1):e15-23. PubMed ID: 22094636
    [Abstract] [Full Text] [Related]

  • 3. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M, Cabrera O, Martinez I, Del Campo JM, Camaraza MA, Sotolongo F, Pérez O, Sierra G.
    Vaccine; 2007 Feb 26; 25(10):1798-805. PubMed ID: 17240485
    [Abstract] [Full Text] [Related]

  • 4. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.
    Kshirsagar N, Mur N, Thatte U, Gogtay N, Viviani S, Préziosi MP, Elie C, Findlow H, Carlone G, Borrow R, Parulekar V, Plikaytis B, Kulkarni P, Imbault N, LaForce FM.
    Vaccine; 2007 Sep 03; 25 Suppl 1():A101-7. PubMed ID: 17532101
    [Abstract] [Full Text] [Related]

  • 5. The Meningitis Vaccine Project.
    LaForce FM, Konde K, Viviani S, Préziosi MP.
    Vaccine; 2007 Sep 03; 25 Suppl 1():A97-100. PubMed ID: 17521780
    [Abstract] [Full Text] [Related]

  • 6. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D, Snape M, Westcar S, Hamaluba M, Yu LM, Begg N, Wysocki J, Czajka H, Maechler G, Boutriau D, Pollard AJ.
    Pediatr Infect Dis J; 2007 Nov 03; 26(11):1057-9. PubMed ID: 17984816
    [Abstract] [Full Text] [Related]

  • 7. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G, Arnemo M, Næss LM, Fjeldheim ÅK, Nome L, Bolstad K, Aase A, Mandiarote A, González H, González D, García L, Cardoso D, Norheim G, Rosenqvist E.
    Vaccine; 2013 Dec 09; 31(51):6097-106. PubMed ID: 24120679
    [Abstract] [Full Text] [Related]

  • 8. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ, Idoko OT, Adegbola RA.
    Vaccine; 2009 Mar 23; 27(14):2023-9. PubMed ID: 19095025
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G, Aase A, Caugant DA, Høiby EA, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E.
    Vaccine; 2005 May 31; 23(29):3762-74. PubMed ID: 15893613
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK, Lee CH, Norris SE, Paul-Satyaseela M, Vann WF, Frasch CE.
    Vaccine; 2007 Nov 14; 25(46):7972-80. PubMed ID: 17936445
    [Abstract] [Full Text] [Related]

  • 15. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H, Heath PT, Papa T, Ruggeberg JU, Johnson N, Sinha R, Balfour G, Booy R.
    Vaccine; 2006 Mar 24; 24(14):2544-9. PubMed ID: 16417952
    [Abstract] [Full Text] [Related]

  • 16. A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children.
    Knuf M, Kieninger-Baum D, Habermehl P, Muttonen P, Maurer H, Vink P, Poolman J, Boutriau D.
    Vaccine; 2010 Jan 08; 28(3):744-53. PubMed ID: 19887137
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger.
    Chippaux JP, Garba A, Ethevenaux C, Campagne G, de Chabalier F, Djibo S, Nicolas P, Ali H, Charrondière M, Ryall R, Bybel M, Schuchat A.
    Vaccine; 2004 Sep 03; 22(25-26):3303-11. PubMed ID: 15308353
    [Abstract] [Full Text] [Related]

  • 18. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, Poolman J, Boutriau D.
    Vaccine; 2007 Dec 12; 25(51):8487-99. PubMed ID: 17996996
    [Abstract] [Full Text] [Related]

  • 19. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F, Ravenscroft N, Djingarey M, Viviani S.
    Vaccine; 2009 Jun 24; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.
    de Voer RM, van der Klis FR, Engels CW, Schepp RM, van de Kassteele J, Sanders EA, Rijkers GT, Berbers GA.
    Vaccine; 2009 Nov 23; 27(50):6974-82. PubMed ID: 19800445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.